Altamira Therapeutics Ltd. Increase Decrease Through Net Exchange Differences Reimbursement Rights At Fair Value
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease Through Net Exchange Differences Reimbursement Rights At Fair Value of -$339.63 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesReimbursementRightsAtFairValue · last filed 2025-04-30
| Period end | Increase Decrease Through Net Exchange Differences Reimbursement Rights At Fair Value 12 month |
|---|---|
| 2024-12-31 | -$339.63K 20-F · filed 2025-04-30 |
| 2023-12-31 | $373.57K 20-F · filed 2025-04-30 |